Urinary Volatile Compounds as Biomarkers for Lung Cancer: A Proof of Principle Study Using Odor Signatures in Mouse Models of Lung Cancer

A potential strategy for diagnosing lung cancer, the leading cause of cancer-related death, is to identify metabolic signatures (biomarkers) of the disease. Although data supports the hypothesis that volatile compounds can be detected in the breath of lung cancer patients by the sense of smell or th...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Koichi, Opiekun, Maryanne, Oka, Hiroaki, Vachani, Anil, Albelda, Steven M., Yamazaki, Kunio, Beauchamp, Gary K.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811722/
https://www.ncbi.nlm.nih.gov/pubmed/20111698
http://dx.doi.org/10.1371/journal.pone.0008819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811722/
https://www.ncbi.nlm.nih.gov/pubmed/20111698
http://dx.doi.org/10.1371/journal.pone.0008819

Ejemplares similares